Let’s Win Pancreatic Cancer Introduces Its Scientific Advisory Board
Let's Win Pancreatic Cancer/letswinpc.org

Let’s Win Pancreatic Cancer Introduces Its Scientific Advisory Board

Let’s Win Pancreatic Cancer shared on LinkedIn:

“Meet our Scientific Advisory Board, the researchers and clinicians who guide the science behind Let’s Win.

They help us identify promising pancreatic cancer research and clinical trials and medically review the resources we share, so patients and families have reliable information to bring to their care teams.

As we mark 10 years, we’re taking a closer look at the teams guiding our mission.

Our Scientific Advisory Board helps more families hear about treatment options and clinical trials they might otherwise miss.

Follow along each month as we continue to spotlight the teams behind Let’s Win.

Read more: Scientific Advisory Board.

Why Our Scientific Advisory Board Matters

The Scientific Advisory Board (SAB) is a group of leading researchers and clinicians who help shape the science behind Let’s Win.

They identify the latest research and clinical trials for our site, share their own work, and medically vet the resources we create.

Through them, our community gets direct access to science-driven treatment options beyond the standard of care.

21 Members․ One Shared Mission:

Connecting patients with Pancreatic Cancer Research․

Allyson J. Ocean, John A. Chabot, Susan M. Domchek, Talia Golan, Manuel Hidalgo, Christine A. Iacobuzio-Donahue, William Isacoff, Elizabeth Jaffee, Anirban Maitra, Gulam A. Manji, Eileen M. O’Reilly, Michael Pishvaian, Diane Reidy-Lagunes, Kim A. Reiss, Felice Schnoll-Sussman, Diane M. Simeone, Jose G. Trevino II, David Tuveson, Robert H. Vonderheide, Raymond C. Wadlow, Brian M. Wolpin․

From the latest research to emerging treatment options, these experts help Let’s Win bring trusted information to patients and families when they need it most.”

You can also read:

How I Treat Pancreatic Cancer in 2026: Global Experts to Convene for OncoDaily Virtual Summit.

OncoDaily

Catherine Alix-Panabières: The First French National Project to Identify a Blood Signature for the Very Early Detection of Pancreatic Cancer.

Shivan Sivakumar: We Are Entering a New Era in Pancreatic Cancer Therapeutics.